Cantharidin-based small molecules as potential therapeutic agents.
about
Cantharidin Induced Oral Squamous Cell Carcinoma Cell Apoptosis via the JNK-Regulated Mitochondria and Endoplasmic Reticulum Stress-Related Signaling PathwaysRecent advances in developing insect natural products as potential modern day medicinesTick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine TargetsSynthesis and anticancer activity evaluation of 3,4-mono- and bicyclosubstituted N-(het)aryl trifluoromethyl succinimidesCantharidins induce ER stress and a terminal unfolded protein response in OSCC.Induction of Suicidal Erythrocyte Death by CantharidinInsects: an underrepresented resource for the discovery of biologically active natural productsTargeting cancer cell mitochondria as a therapeutic approach: recent updates.Cantharidin inhibits competitively heme-Fe(III) binding to the FA1 site of human serum albumin.Synthesis of Canthardin Sulfanilamides and Their Acid Anhydride Analogues via a Ring-Opening Reaction of Activated Aziridines and Their Associated Pharmacological Effects.New Norcantharidin Analogs: Synthesis and Anticancer Activity.Evaluation of DNA damage induced by norcantharidin in human cultured lymphocytes.Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass.Protective effect of norcantharidin on collagen-induced arthritis rats.Draft genomes of two blister beetles Hycleus cichorii and Hycleus phaleratus.Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin.Exoconformers ofN-(pyridin-2-yl)- andN-(pyridin-3-yl)norbornene-5,6-dicarboximide crystalsChemoselective flow hydrogenation approaches to isoindole-7-carboxylic acids and 7-oxa-bicyclio[2.2.1]heptanes
P2860
Q28554836-6634B67E-5E66-472A-A8B2-C29BDCF40FFAQ33634334-173544CB-6B94-4237-B3D5-C8868ADF5DF2Q33766134-B2C9AEF5-94AF-4E7A-823F-F3DC1CB76E53Q34503993-41E1CC2C-FDD2-45F5-9594-6F9D09A5E86FQ34989877-2E08E9CF-E42F-4527-9720-2B450EE85611Q35996586-1A11B5CA-6CE4-4E83-8628-E8B86975E7F8Q38656223-FD670025-3974-4FDD-A958-C1C53FF73648Q38668524-99589DC9-FE39-49AE-9835-60D8AE345422Q38728217-B9D1655C-EA7A-4E21-A447-8A9E398487ECQ38801809-84E456DE-E617-4F94-9595-B538EF2ABB71Q38821108-F55AFC5C-9EEC-4D97-9940-BED0824EA9E1Q46634780-BEF2DA66-8033-458E-AD48-9D88A86AB87CQ48134591-F6D91F30-970E-448D-B7CC-1DF04451BCB7Q49629345-A03C7294-E920-4FF4-9C64-65116085A3C0Q49998275-2B9920EE-EEC3-4AF6-BD22-DF01C3DE5F17Q55347232-445B0ED8-1C09-4678-86E0-E7BFB07AB823Q57663331-0AF1B8CB-8722-47D7-B5C2-DEBE3C976581Q58200374-C954FD74-3F7E-459A-9155-00F1274066BA
P2860
Cantharidin-based small molecules as potential therapeutic agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cantharidin-based small molecules as potential therapeutic agents.
@en
type
label
Cantharidin-based small molecules as potential therapeutic agents.
@en
prefLabel
Cantharidin-based small molecules as potential therapeutic agents.
@en
P2860
P356
P1476
Cantharidin-based small molecules as potential therapeutic agents
@en
P2093
Leonor Y Vargas Méndez
P2860
P304
P356
10.1111/CBDD.12180
P577
2013-08-09T00:00:00Z